Annexin V, Human Recombinant: Precision Tool for Apoptosis and Cell Death Research

Executive Summary: Annexin V, human recombinant (SKU K2064), is a calcium-dependent phosphatidylserine binding protein used for detecting early apoptosis through specific recognition of PS exposed on the outer plasma membrane leaflet. Its application enables reproducible apoptosis assays across immune and cancer research contexts (Annexin V, human recombinant). The reagent is supplied at 1 mg/mL in PBS, pH 7.4 and should be stored at -20°C for stability. It remains unlabeled for flexible conjugation with detection tags and is validated as an early apoptosis marker in both peer-reviewed literature and internal benchmarking. The product is intended strictly for research use and not for diagnostic or therapeutic purposes.

Biological Rationale

Phosphatidylserine (PS) is a negatively charged phospholipid predominantly localized to the inner leaflet of the plasma membrane in healthy cells. During the early stages of apoptosis, PS is actively translocated to the outer leaflet, serving as a hallmark of programmed cell death. The ability to detect PS externalization is critical for distinguishing apoptotic cells from viable or necrotic populations, particularly in immune regulation, cancer, and developmental biology (Annexin V: High-Fidelity Early Apoptosis Detection Reagent extends this by detailing assay specificity in complex samples). Annexin V, a member of the annexin family, binds PS in a strictly calcium-dependent manner, making it an indispensable probe for apoptosis studies. This mechanism underpins its utility as an apoptosis detection reagent in workflows ranging from flow cytometry to microscopy (Cao et al. 2025).

Mechanism of Action of Annexin V, human recombinant

Annexin V, human recombinant, operates by forming a high-affinity complex with PS exposed on the extracellular leaflet of the plasma membrane. The binding is strictly dependent on the presence of calcium ions (typically ≥1.5 mM Ca²⁺). This interaction is highly specific and does not occur with other phospholipids under the same conditions. Upon PS exposure, Annexin V can be detected via conjugated fluorophores (e.g., FITC, PE) or through competition assays with labeled analogs. In addition to its diagnostic role, Annexin V inhibits phospholipase A1 activity and blood coagulation by outcompeting prothrombin for PS binding sites (APExBIO product information). The unlabeled nature of this reagent permits custom labeling for diverse detection platforms.

Evidence & Benchmarks

• Annexin V specifically binds to PS on apoptotic cells in a calcium-dependent manner, enabling discrimination between viable and early apoptotic populations (Cao et al. 2025).
• During apoptosis, PS externalization is an early, reliable marker, detectable prior to DNA fragmentation or loss of membrane integrity (Gold-Standard Apoptosis Detection Reagent elaborates on kinetic benchmarks for PS exposure).
• Recombinant Annexin V is validated for use in flow cytometry, fluorescence microscopy, and competition binding assays with high specificity and reproducibility (product documentation).
• In immune research, Annexin V assays reveal that miR-519d-3p in placenta-derived exosomes suppresses Jurkat T cell apoptosis, supporting studies of immune tolerance in preeclampsia (Cao et al. 2025).
• Externalized PS detected by Annexin V is a feature not only of classical apoptosis but also of regulated cell death modalities; accurate gating and controls are essential (Scenario-Driven Reliability provides troubleshooting scenarios for assay design).

Applications, Limits & Misconceptions

Annexin V, human recombinant, is widely adopted for apoptosis assays in immunology, oncology, and cell death research. Its versatility extends to quantifying cell death in response to drugs, stress, or immune modulation, including the study of exosome-mediated immune alterations in disease models like preeclampsia (Cao et al. 2025). Researchers can flexibly conjugate the reagent with fluorophores or biotin for multiplexed workflows. However, it is not suitable as a late apoptosis or necrosis marker, since membrane integrity loss can allow non-specific binding. Misinterpretation may arise if used without proper calcium concentrations or live/dead discrimination. For an advanced overview of translational applications, Annexin V and the Next Frontier in Apoptosis Detection discusses how the product integrates with modern immune and cancer models, highlighting the role of PS detection in mechanistic studies.

Common Pitfalls or Misconceptions

• Annexin V does not distinguish between apoptosis and other forms of cell death with PS exposure, such as necroptosis, unless combined with viability dyes.
• Binding is strictly calcium-dependent; omission of Ca²⁺ or chelation (e.g., with EDTA) abolishes signal.
• Loss of membrane integrity (late apoptosis/necrosis) may cause Annexin V to label all cells non-specifically.
• Incorrect storage (e.g., repeated freeze-thaw cycles) can reduce binding efficiency; always store at -20°C as indicated in the product information.
• It is intended for research use only; diagnostic or therapeutic applications are not validated.

Workflow Integration & Parameters

• Formulation and Storage: Supplied as a 1 mg/mL solution in PBS, pH 7.4; store at -20°C. Lyophilized forms can be reconstituted in PBS or water to 1–5 mg/mL.
• Labeling: Unlabeled protein can be conjugated to fluorophores (e.g., FITC, PE) or biotin for detection. Conjugation should follow manufacturer protocols for amine-reactive dyes.
• Assay Buffer: Always include 1.5–2.5 mM CaCl₂ in binding buffer to ensure optimal PS recognition.
• Centrifugation: Briefly centrifuge vial prior to use to ensure solution homogeneity.
• Controls: Include live, apoptotic (e.g., staurosporine-treated), and necrotic controls for accurate gating.
• Detection: Combine with viability dyes (e.g., PI, 7-AAD) to discriminate apoptosis from necrosis.

Conclusion & Outlook

Annexin V, human recombinant, provided by APExBIO, is a validated, flexible apoptosis detection reagent that underpins modern cell death research. Its role as a phosphatidylserine binding protein is central to studies of immune regulation, cancer therapy response, and disease modeling, including recent advances in understanding immune tolerance breakdown in preeclampsia (Cao et al. 2025). The product’s robust performance and adaptability make it a cornerstone for researchers seeking reproducible and sensitive apoptosis assays. Moving forward, integrating Annexin V-based detection with multi-omics and advanced cell sorting will further refine our understanding of cell fate decisions and immune homeostasis.